These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38417792)

  • 1. A Modern Approach to Stability Studies via Bayesian Linear Mixed Models Incorporating Auxiliary Effects.
    Cordero M; Meinfelder F; Eilert T
    J Pharm Sci; 2024 Jul; 113(7):1779-1793. PubMed ID: 38417792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the distribution of batch shelf lives.
    Quinlan M; Stroup W; Christopher D; Schwenke J
    J Biopharm Stat; 2013; 23(4):897-920. PubMed ID: 23786624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the performance of the ICH guidelines for shelf life estimation.
    Quinlan M; Stroup W; Schwenke J; Christopher D
    J Biopharm Stat; 2013; 23(4):881-96. PubMed ID: 23786363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Current Practices in Shelf Life Estimation.
    Capen R; Christopher D; Forenzo P; Huynh-Ba K; LeBlond D; Liu O; O'Neill J; Patterson N; Quinlan M; Rajagopalan R; Schwenke J; Stroup W
    AAPS PharmSciTech; 2018 Feb; 19(2):668-680. PubMed ID: 28948584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study.
    Almalik O; Nijhuis MB; van den Heuvel ER
    J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.
    Montes RO; Burdick RK; Leblond DJ
    PDA J Pharm Sci Technol; 2019; 73(1):39-59. PubMed ID: 30361286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Shelf Life Through Tolerance Intervals.
    Schwenke J; Quinlan M; Stroup W; Forenzo P
    AAPS PharmSciTech; 2020 Oct; 21(8):290. PubMed ID: 33079300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bayesian approach to Arrhenius prediction of shelf-life.
    Su XY; Li Wan Po A; Yoshioka S
    Pharm Res; 1994 Oct; 11(10):1462-6. PubMed ID: 7855053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the shelf life of pharmaceutical products.
    Capen R; Christopher D; Forenzo P; Ireland C; Liu O; Lyapustina S; O'Neill J; Patterson N; Quinlan M; Sandell D; Schwenke J; Stroup W; Tougas T
    AAPS PharmSciTech; 2012 Sep; 13(3):911-8. PubMed ID: 22729779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability analysis with discrete responses.
    Chow SC; Shao J
    J Biopharm Stat; 2003 Aug; 13(3):451-62. PubMed ID: 12921393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical evaluation of stability data: criteria for change-over-time and data variability.
    Bar R
    PDA J Pharm Sci Technol; 2003; 57(5):369-77. PubMed ID: 14677629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability analysis using mixed models: A critique of tolerance interval methods and a probabilistic solution.
    Altan S; Faya P; Rauk AP; LeBlond D; Seaman JW; Banton D
    Pharm Stat; 2023; 22(5):784-796. PubMed ID: 37164770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Shelf Life Through Tolerance Intervals Extended to Nonlinear Response Trends.
    Schwenke J; Stroup W; Quinlan M; Forenzo P
    AAPS PharmSciTech; 2023 Mar; 24(4):80. PubMed ID: 36944868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies.
    McMahon ME; Abbott A; Babayan Y; Carhart J; Chen CW; Debie E; Fu M; Hoaglund-Hyzer C; Lennard A; Li H; Mazzeo T; McCaig L; Pischel S; Qiu F; Stephens D; Timpano R; Webb D; Wolfe C; Woodlief K; Wu Y
    AAPS J; 2021 Sep; 23(6):107. PubMed ID: 34529169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of shelf-life estimates for a human insulin pharmaceutical preparation using the matrix and full-testing approaches.
    Oliva A; Fariña J; Llabrés M
    Drug Dev Ind Pharm; 2003 May; 29(5):513-21. PubMed ID: 12779281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using accelerated drug stability results to inform long-term studies in shelf life determination.
    Faya P; Seaman JW; Stamey JD
    Stat Med; 2018 Jul; 37(17):2599-2615. PubMed ID: 29766536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian Approach to Kinetic Modeling of Accelerated Stability Studies and Shelf Life Determination.
    Chau J; Altan S; Burggraeve A; Coppenolle H; Kifle YW; Prokopcova H; Van Daele T; Sterckx H
    AAPS PharmSciTech; 2023 Nov; 24(8):250. PubMed ID: 38036798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence tests for shelf life and average drug content in stability studies.
    Djira GD; Hothorn LA; Tsong Y
    J Biopharm Stat; 2008; 18(5):985-95. PubMed ID: 18781530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.